Literature DB >> 23175664

High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center.

Stephanie B Tsai, David C Seldin, Karen Quillen, John L Berk, Frederick L Ruberg, Hans Meier-Ewert, J Mark Sloan, Gheorghe Doros, Kathleen T Finn, Martha Skinner, Vaishali Sanchorawala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23175664     DOI： 10.1182/blood-2012-09-457341

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.

Authors:  S Rosengren; U-H Mellqvist; H Nahi; K Forsberg; S Lenhoff; O Strömberg; L Ahlberg; O Linder; K Carlson
Journal:  Bone Marrow Transplant       Date:  2016-10-03       Impact factor: 5.483

2.  Hospital admissions following outpatient administration of high-dose melphalan and autologous SCT for AL amyloidosis.

Authors:  B Freeman; D Brauneis; D C Seldin; K Quillen; J M Sloan; A S Renteria; A C Shelton; T Teschner; K T Finn; V Sanchorawala
Journal:  Bone Marrow Transplant       Date:  2014-06-23       Impact factor: 5.483

3.  Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Anita D'Souza; Angela Dispenzieri; Baldeep Wirk; Mei-Jie Zhang; Jiaxing Huang; Morie A Gertz; Robert A Kyle; Shaji Kumar; Raymond L Comenzo; Robert Peter Gale; Hillard M Lazarus; Bipin N Savani; Robert F Cornell; Brendan M Weiss; Dan T Vogl; César O Freytes; Emma C Scott; Heather J Landau; Jan S Moreb; Luciano J Costa; Muthalagu Ramanathan; Natalie S Callander; Rammurti T Kamble; Richard F Olsson; Siddhartha Ganguly; Taiga Nishihori; Tamila L Kindwall-Keller; William A Wood; Tomer M Mark; Parameswaran Hari
Journal:  J Clin Oncol       Date:  2015-09-14       Impact factor: 44.544

4.  Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115.

Authors:  V Sanchorawala; A Hoering; D C Seldin; K T Finn; S A Fennessey; R Sexton; B Mattar; H F Safah; L A Holmberg; R M Dean; R Z Orlowski; B Barlogie
Journal:  Bone Marrow Transplant       Date:  2013-07-15       Impact factor: 5.483

5.  Improved Treatment Related Mortality in Patients with Primary Systemic Amyloidosis (AL Amyloidosis) undergoing Autologous Hematopoietic Stem Cell Transplant (aHSCT).

Authors:  Akshata Pandit; Lai Wei; Luis Bustamante; Patrick Elder; William B S Falk; Megan Sell; Ashley Rosko; Don M Benson; Steven M Devine; Craig C Hofmeister; Yvonne A Efebera
Journal:  Arch Hematol Blood Dis       Date:  2019

6.  Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved.

Authors:  Abdullah S Al Saleh; M Hasib Sidiqi; Eli Muchtar; Angela Dispenzieri; Francis K Buadi; David Dingli; Martha Q Lacy; Rahma M Warsame; Wilson I Gonsalves; Taxiarchis V Kourelis; William J Hogan; Suzanne R Hayman; Prashant Kapoor; Shaji K Kumar; Morie A Gertz
Journal:  Biol Blood Marrow Transplant       Date:  2019-05-02       Impact factor: 5.742

Review 7.  Advances in the Treatment of Cardiac Amyloidosis.

Authors:  Ariane Vieira Scarlatelli Macedo; Pedro Vellosa Schwartzmann; Breno Moreno de Gusmão; Marcelo Dantas Tavares de Melo; Otávio Rizzi Coelho-Filho
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

8.  Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis.

Authors:  Yasunobu Sekiguchi; Mutsumi Wakabayashi; Hiroko Iizuka; Haruko Takizawa; Keiji Sugimoto; Sakura Sakajiri; Tadaaki Inano; Yasutaka Fukuda; Yasuharu Hamano; Shigeki Tomita; Hiroshi Izumi; Hiroyuki Isogai; Mitsuo Okubo; Noriko Nakamura; Tomohiro Sawada; Kimihiro Matsumoto; Masaaki Noguchi
Journal:  J Clin Exp Hematop       Date:  2020-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.